本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Janux Therapeutics, Inc.

18.68
+0.08000.43%
盤後18.680.00000.00%17:41 EDT
成交量:107.44萬
成交額:2,018.68萬
市值:11.42億
市盈率:-11.37
高:19.14
開:18.72
低:18.55
收:18.60
52周最高:35.34
52周最低:12.12
股本:6,113.68萬
流通股本:4,981.62萬
量比:1.17
換手率:2.16%
股息:- -
股息率:- -
每股收益(TTM):-1.6429
每股收益(LYR):-1.8336
淨資產收益率:-10.70%
總資產收益率:-8.80%
市淨率:1.23
市盈率(LYR):-10.19

資料載入中...

2026/08/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/29

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/24

重要事件披露

Form 8-K - Current report
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/28

重要事件披露

Form 8-K - Current report
2026/04/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]